A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

SurgiCount+ Safety-Sponge System Launches Reports Stryker

SurgiCount+ Safety-Sponge System, is Stryker’s next generation surgical sponge counting technology.

SurgiCount+ is Stryker’s most intelligent surgical sponge counting technology and allows healthcare providers to count and scan sponges and connect to hospital electronic medical records (EMR). Built on Stryker’s existing technology, it is designed to assist with sponge management, a leading safety concern in the operating room (OR) due to inadequate tools, manual processes and inconsistent practices.

One out of every 11 cases has a missing sponge,1 resulting in nurses spending almost 10 minutes searching.2 Current data show sponges are the number one retained surgical item3 – occurring 11 times a day in the U.S. alone.1 This negatively impacts patients and causes millions of dollars in costs for hospitals each year.

“Stryker is collaborating with surgical teams across the country to create safer ORs and equip healthcare providers with the tools needed to avoid retained surgical sponges,” said Mike Carlin, Vice President and General Manager of Stryker’s Surgical Technologies business. “We want healthcare providers to know they can count on us to make zero retained surgical sponges* the expectation and reality and provide certainty when they need it most.”

SurgiCount+ advances Stryker’s mission of making healthcare better by simplifying workflow and streamlining processes, resulting in less time spent searching for missing sponges. To date, medical staff have trusted SurgiCount in over 16 million procedures with zero retained sponges*. Features of SurgiCount+ include:

  • UHF-RFID tagged sponges enabling unique identification, eliminating false-correct, duplicate or unknown counts
  • A wireless reader for scanning, counting and finding sponges in the operating room
  • Intuitive, user-friendly tablet interface
  • A workstation stand equipped with sponge hanging bags and sterile reader covers situated on wheels for easy maneuverability and minimal floor space
  • A digital platform enabling EMR connectivity and documented proof

1 Makary, M et al. “Medical error—the third leading cause of death in the US.” The BMJ (May 2016). Web. Sept. 2016.

2 Double-blinded survey of 154 Operating Room Nurses from 154 different facilities across the United States. Data on file internally. Conducted August 2020.

3 The Joint Commission. “Preventing unintended retained foreign objects.” Sentinel Event Alert. Issue 51. Oct. 2013.

* When used and implemented correctly

SourceStryker
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy